Related Experiment Videos
Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells.
Chao Yan Liu1, Manuela Battaglia, Seon Ho Lee
1Blood Research Institute, The Blood Center of Southeastern Wisconsin, Milwaukee, WI 53226, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|February 25, 2005
Summary
Platelet factor 4 (PF4) stimulates T regulatory cells while inhibiting other T cells, potentially altering immune responses. This suggests PF4 may play a role in immune-mediated disorders linked to platelet activation.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- CD4(+)CD25(+) T regulatory (Tr) cells are crucial for immune response regulation.
- Platelet factor 4 (PF4) is a chemokine known to inhibit T cell proliferation and cytokine release.
Purpose of the Study:
- To investigate the effect of human PF4 on CD4(+)CD25(+) Tr cells and CD4(+)CD25(-) T cells.
- To explore PF4's role in immune regulation and its potential link to platelet-related disorders.
Main Methods:
- Co-culture experiments involving human CD4(+)CD25(+) Tr cells and CD4(+)CD25(-) T cells.
- Assessment of T cell proliferation and regulatory function in the presence of PF4.
Main Results:
- Human PF4 stimulated the proliferation of CD4(+)CD25(+) Tr cells.
- PF4 inhibited the proliferation of CD4(+)CD25(-) T cells.
- PF4-exposed Tr cells lost their ability to suppress CD4(+)CD25(-) T cell proliferation.
Conclusions:
- Human PF4 modulates T cell responses by promoting Tr cell proliferation and impairing their suppressive function.
- PF4's actions suggest a novel role in regulating human immune responses.
- Findings may be relevant to immune-mediated disorders involving platelet activation, such as heparin-induced thrombocytopenia.